Janssen Supply Group, a subsidiary of Johnson & Johnson, has become the first occupant of a biopharmaceutical manufacturing facility in Holly Springs, N.C. This $2 billion project, developed by FUJIFILM Diosynth Biotechnologies (FDB), encompasses 1 million square feet and is expected to be fully operational by 2025. Located in the Triangle region and just 20 miles from downtown Raleigh, N.C., the state-of-the-art facility is the result of a collaboration between Janssen Supply Group and FDB. Specifically, it supports their clinical and commercial manufacturing efforts; strengthens their partnership; and contributes to the production of Janssen’s clinical and commercial pipeline.
FDB announced its plans for the Holly Springs facility in January 2021, and construction began in October of the same year. After approximately two years since its groundbreaking, CEO and President, Lars Petersen, revealed that the final product would be a complex spanning nearly 1 million square feet and consisting of seven buildings. This expansion is expected to create 725 manufacturing jobs in North Carolina.
Once completed, the Holly Springs life sciences facility is set to become the largest biopharmaceutical manufacturing facility in North America for end-to-end cell culture contract development and manufacturing (CDMO). Equipped with advanced technology and state-of-the-art equipment, it boasts two spacious manufacturing suites with four 20,000 L bioreactors. This enables the facility to produce drug substances, packaging, assembly, and labeling. Additionally, the facility has the capacity to expand with an additional 24 bioreactors.
Moreover, sustainability is a central focus of the Holly Springs project with the facility operating solely on clean energy and implementing advanced waste disposal and recycling practices.
Fujifilm Diosynth, a division of Fujifilm, is the parent company known for its historical background in photography. In recent years, Fujifilm has redirected its resources toward the health care sector. As a contract drug manufacturer, FDB specializes in large-scale production of medications developed by other pharmaceutical companies, rather than developing drugs themselves.
Looking for office and lab space opportunities for lease? Select any of the locations linked below or visit the CommercialCafe home page to start your search!
